Stockreport

A Fresh Look at Disc Medicine's Valuation After Bitopertin NDA Submission and Positive Phase 2 Data [Yahoo! Finance]

Disc Medicine, Inc.  (IRON) 
PDF Positive Phase 2 results support this filing. See our latest analysis for Disc Medicine. Disc Medicine's bold move on the bitopertin NDA builds on momentum from rece [Read more]